Investor Alert

New York Markets Close in:

Market Snapshot Winners and Losers

Deciphera Pharmaceuticals Inc.

NAS: DCPH

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Deciphera Pharmaceuticals Inc.

Market open

DCPH
/zigman2/quotes/203556943/composite

$

16.47

Change

-0.25 -1.47%

Volume

Volume 216,915

Feb 7, 2023, 12:13 p.m.

Real time quotes

/zigman2/quotes/203556943/composite

Previous close

$ 16.71

$ 16.47

Change

-0.25 -1.47%

Day low

Day high

$16.15

$17.16

Open
Open: 16.54

52 week low

52 week high

$6.51

$22.76

Open

Market cap

$1.13B

Average volume

781,515

P/E ratio

N/A

Rev. per Employee

$435,321

EPS

-3.46

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/dcph

MarketWatch News on DCPH

  2. Deciphera Pharmaceuticals stock price target raised to $18 from $11 at Stifel Nicolaus

    5:36 a.m. Sept. 27, 2022

    - Tomi Kilgore

  3. Deciphera Pharmaceuticals downgraded to hold from buy at Truist

    8:04 a.m. Nov. 8, 2021

    - Tomi Kilgore

  4. Deciphera Pharmaceuticals downgraded to hold from buy at Stifel Nicolaus

    7:58 a.m. Nov. 8, 2021

    - Tomi Kilgore

  5. Deciphera Pharmaceuticals stock price target cut to $65 from $84 at Truist

    6:16 a.m. Oct. 4, 2021

    - Tomi Kilgore

  6. Deciphera Pharmaceuticals coverage resumed at Stifel with buy stock rating and $60 target price

    6:05 a.m. Sept. 30, 2021

    - Tonya Garcia

  7. Deciphera Pharmaceuticals started at buy with $75 stock price target at Stifel Nicolaus

    9:16 a.m. Dec. 3, 2020

    - Tomi Kilgore

  8. Callon, Fitbit, Genco Shipping, and Other 13D Filings

    9:30 p.m. Nov. 22, 2019

    - Barron's Online

  9. Deciphera Pharmaceuticals stock price target raised to $60 from $45 at SunTrust RH

    7:40 a.m. Aug. 14, 2019

    - Tomi Kilgore

  11. Deciphera Pharmaceuticals stock rockets 126% premarket after positive trial data for GIST treatment

    7:32 a.m. Aug. 13, 2019

    - Tomi Kilgore

  12. Deciphera Pharmaceuticals started at buy with $42 stock price target at Deutsche Bank

    1:17 p.m. July 18, 2019

    - Tomi Kilgore

  13. Deciphera Pharmaceuticals started at outperform with $47 stock price target at Raymond James

    7:25 a.m. Aug. 29, 2018

    - Tomi Kilgore

  14. Deciphera Pharmaceuticals started at buy with $60 stock price target at SunTrust RH

    6:54 a.m. July 5, 2018

    - Tomi Kilgore

  15. Deciphera Pharmaceuticals started at overweight with $30 stock price target at J.P. Morgan

    6:40 a.m. Oct. 23, 2017

    - Tomi Kilgore

Analyst Ratings

/news/nonmarketwatch/company/us/dcph

Other News on DCPH

  1. 10-K: DECIPHERA PHARMACEUTICALS, INC.

    7:20 a.m. Today

    - Edgar Online - (EDG = 10Q, 10K)

  6. 10-Q: DECIPHERA PHARMACEUTICALS, INC.

    6:12 a.m. Nov. 3, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  8. Will Ayvakit Aid Blueprint Medicines (BPMC) Amid Rivalry?

    10:10 a.m. Oct. 5, 2022

    - Zacks.com

  11. Deciphera Pharmaceuticals (DCPH) Presents at ESMO Congress 2022

    2:35 p.m. Sept. 16, 2022

    - Seeking Alpha

  20. BioMarin's (BMRN) Q2 Earnings Top, Voxzogo Drives Sales

    6:31 a.m. Aug. 4, 2022

    - Zacks.com

  21. Loading more headlines...
/news/pressrelease/company/us/dcph

Press Releases on DCPH

  1. Deciphera Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results

    7:00 a.m. Today

    - BusinessWire - BZX

  21. Loading more headlines...

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.